Mark A. Hyde
( out of 147 reviews )

Mark A. Hyde, PhD, PA-C

Languages spoken: English, Russian

Clinical Locations

Stansbury Health Center

Tooele
Directions

Sugar House Health Center

Dermatology
Salt Lake City
801-581-2955
Directions

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955
Directions

  • Mark Hyde, PhD, PA-C has specialized expertise in the treatment of patients with skin diseases including melanoma and non-melanoma skin cancer. As a Physician Assistant, he is board certified in primary care. Dr. Hyde has assisted in Mohs micrographic surgery, having performed more than 9000 procedures at the Huntsman Cancer Institute.

    Specialties

    Patient Rating

    4.9 /5
    ( out of 147 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 23, 2025
    STANSBURY HEALTH CENTER

    Mark and MA were very good, respectful and caring

    January 16, 2025
    STANSBURY HEALTH CENTER

    He was very caring and made me feel comfortable about what he was going to do.

    January 16, 2025
    STANSBURY HEALTH CENTER

    Great

    January 15, 2025
    STANSBURY HEALTH CENTER

    I am very picky about which PA's can give me care. Mark is one of the few that I can say I like very much and appreciate his knowledge in Dermatology.

    January 14, 2025
    SUGAR HOUSE HEALTH CENTER

    He is a great Dermatologist. Keeps you at ease to go over treatment options.

    January 09, 2025
    SUGAR HOUSE HEALTH CENTER

    Mark helped me with the immediate problem that I was dealing with but also provided valuable insight to another issue that I was experiencing. I left his office with a resolution to one problem and path forward on another. Thank you, Mark!

    January 09, 2025
    SUGAR HOUSE HEALTH CENTER

    Don't hesitate to make an appt with this fellow

    January 09, 2025
    SUGAR HOUSE HEALTH CENTER

    Dr. Hyde listened and provided care that was specific to me and based on my history, which was so nice because it was the first time I had seen him.

    January 05, 2025
    SUGAR HOUSE HEALTH CENTER

    I felt very well cared for by Mark Hyde and the entire staff. All my questions were answered clearly. He is thoughtful, friendly and professional.

  • Mark Hyde, PhD, PA-C has specialized expertise in the treatment of patients with skin diseases including melanoma and non-melanoma skin cancer. As a Physician Assistant, he is board certified in primary care. Dr. Hyde has assisted in Mohs micrographic surgery, having performed more than 9000 procedures at the Huntsman Cancer Institute.

    Board Certification and Academic Information

    Academic Departments Dermatology -Assistant Professor (Clinical)

    Education history

    Certification Genetics/Genomics - Stanford Certificate
    Doctoral Training Public Health and Epidemiology - University of Utah Ph.D.
    Graduate Training Physician Assistant - Midwestern University M.M.Sc.
    Undergraduate Political Science - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Ruiz J, Hyde M, Perry A, Brouha B (2023). Genomic Evaluation of Clinically Ambiguous Pigmented Lesions. J Clin Aesthet Dermatol, 16(6), 44-45. (Read full article)
    2. Hyde MA, Grossman D, Wu YP, Buys S, Gren LH, Hashibe M (2020). Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients. JAAPA, 33(6), 35-41. (Read full article)
    3. Clark JJ, Woodcock A, Cipriano SD, Hyde MA, Edwards SL, Frost CJ, Eliason MJ (2016). Community perceptions about the use of black salve. J Am Acad Dermatol, 74(5), 1021-3. (Read full article)
    4. Thomas E, Coombs J, Kim J, Hyde M (Summer 2014). Physician Assistants in Dermatology: A Survey of Fellows of the SDPA. 8(3), 47-48.
    5. Gaffney S, Goldgar C, Hyde M (2012). Roles and responsibilities of physician assistants practicing in Mohs surgery. JAAPA, 25(10), 52. (Read full article)
    6. Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM (2012). A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol, 148(5), 592-6. (Read full article)
    7. Gifford A, Hyde M, Stoehr JD (2011). PAs in the ED: do physicians think they increase the malpractice risk? JAAPA, 24(6), 34, 36-8. (Read full article)
    8. Hyde MA, Hadley ML, Roberson C, Jacobson A, Pappas L, Bowen GM (2010). Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons. Dermatol Surg, 36(11), 1700-3. (Read full article)
    9. Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D (2010). Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg, 36(7), 1087-98. (Read full article)

    Letter

    1. Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D (2014). Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ. [Letter to the editor]. J Am Acad Dermatol, 71(4), 835-8. (Read full article)
    2. Duffy K, Hyde MA, Tanner B, Goldgar D, Bowen AR, Florell SR, Bowen GM (2010). Anatomic variability in superficial blood vessel and lymphatic vessel density. [Letter to the editor]. J Cutan Pathol, 37(10), 1108-9. (Read full article)

    Other

    1. Mark Hyde, PhD, PA-C (2024). Elevate-Derm ALLIANCE Estrogen-Related Skin Tumors - Connection to Gender Transition?